Meeting to be held on June 4-5 hosted by Maxim.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLTE:
- Belite Bio’s Promising Outlook: FDA Breakthrough Designation and Upcoming Milestones Boost Buy Rating
- Yi Chen Recommends Buy Rating for Belite Bio Due to Breakthrough Therapy Designation and Promising Trial Progress
- Belite Bio’s Tinlarebant Receives FDA Breakthrough Therapy Designation for Stargardt Disease
- Belite Bio announces Breakthrough Therapy Designation for Tinlarebant from FDA
- Belite Bio’s Earnings Call Highlights Clinical Progress and Financial Strength